Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,979 | 1,197 | 99.2% |
| Education | $159.54 | 8 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,285 | 124 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,179 | 136 | $0 (2024) |
| Lilly USA, LLC | $1,471 | 89 | $0 (2024) |
| ABBVIE INC. | $1,348 | 67 | $0 (2024) |
| PFIZER INC. | $1,220 | 120 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,206 | 65 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $825.61 | 45 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $669.49 | 40 | $0 (2024) |
| Allergan, Inc. | $596.82 | 48 | $0 (2020) |
| Merck Sharp & Dohme LLC | $559.11 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,426 | 121 | Novo Nordisk Inc ($395.87) |
| 2023 | $2,535 | 141 | ABBVIE INC. ($343.66) |
| 2022 | $2,715 | 163 | Novo Nordisk Inc ($296.96) |
| 2021 | $2,770 | 171 | AbbVie Inc. ($331.17) |
| 2020 | $2,352 | 148 | AstraZeneca Pharmaceuticals LP ($365.60) |
| 2019 | $2,206 | 144 | Novo Nordisk Inc ($369.76) |
| 2018 | $2,160 | 163 | AstraZeneca Pharmaceuticals LP ($297.83) |
| 2017 | $1,974 | 154 | AstraZeneca Pharmaceuticals LP ($302.08) |
All Payment Transactions
1,205 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.57 | General |
| 12/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.88 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.96 | General |
| 10/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.79 | General |
| 09/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: DIABETES | ||||||
| 09/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Gastroenterology | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 903 | 1,218 | $164,125 | $65,141 |
| 2022 | 17 | 1,017 | 1,358 | $187,360 | $73,296 |
| 2021 | 19 | 1,127 | 1,503 | $188,098 | $79,573 |
| 2020 | 19 | 1,204 | 1,625 | $183,397 | $74,615 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 210 | 438 | $80,154 | $27,414 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 186 | 186 | $49,104 | $23,819 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 51 | $13,260 | $4,620 | 34.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 175 | 175 | $6,475 | $3,154 | 48.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 154 | 154 | $5,698 | $2,775 | 48.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $5,726 | $2,256 | 39.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 81 | $2,268 | $780.47 | 34.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 34 | 44 | $440.00 | $150.04 | 34.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 18 | 21 | $420.00 | $115.95 | 27.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 27 | 54 | $580.00 | $56.86 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 200 | 455 | $83,265 | $27,181 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 166 | 166 | $43,824 | $21,441 | 48.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 58 | 58 | $5,720 | $3,958 | 69.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 38 | $9,880 | $3,247 | 32.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 152 | 152 | $5,624 | $2,771 | 49.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 153 | 153 | $5,661 | $2,741 | 48.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 16 | 16 | $6,240 | $2,297 | 36.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 18 | 18 | $7,200 | $2,184 | 30.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $5,317 | $2,107 | 39.6% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 15 | 16 | $5,920 | $1,928 | 32.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 61 | 64 | $3,840 | $1,839 | 47.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 32 | 63 | $1,764 | $648.71 | 36.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 13 | $1,365 | $498.18 | 36.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 42 | 59 | $590.00 | $203.02 | 34.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $420.00 | $135.71 | 32.3% |
About Dr. Eduardo Martinez, MD
Dr. Eduardo Martinez, MD is a Internal Medicine healthcare provider based in Largo, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417955337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eduardo Martinez, MD has received a total of $19,139 in payments from pharmaceutical and medical device companies, with $2,426 received in 2024. These payments were reported across 1,205 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($18,979).
As a Medicare-enrolled provider, Martinez has provided services to 4,251 Medicare beneficiaries, totaling 5,704 services with total Medicare billing of $292,624. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Largo, FL
- Active Since 07/13/2005
- Last Updated 06/28/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417955337
Products in Payments
- FARXIGA (Drug) $1,498
- Ozempic (Drug) $1,158
- JARDIANCE (Drug) $1,045
- VRAYLAR (Drug) $678.97
- XIFAXAN (Drug) $676.90
- UBRELVY (Drug) $645.34
- REXULTI (Drug) $580.33
- TRULICITY (Drug) $541.06
- NURTEC ODT (Drug) $436.74
- JANUVIA (Drug) $386.94
- EMGALITY (Drug) $379.50
- EVENITY (Biological) $366.08
- Rybelsus (Drug) $332.90
- TRINTELLIX (Drug) $325.93
- QULIPTA (Drug) $311.73
- TRELEGY ELLIPTA (Drug) $306.78
- Vascepa (Drug) $305.45
- SOLIQUA 100/33 (Biological) $301.16
- Kerendia (Drug) $292.43
- XARELTO (Drug) $291.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Largo
Dr. Brian Lake, D.o, D.O
Internal Medicine — Payments: $1.1M
Rakhee Shah, D.o, D.O
Internal Medicine — Payments: $18,119
Randal Worth, Do, DO
Internal Medicine — Payments: $15,659
Vlad Badescu, Md, MD
Internal Medicine — Payments: $14,612
Jennifer Kudelko, D.o, D.O
Internal Medicine — Payments: $14,033
Matthew Smith, M.d, M.D
Internal Medicine — Payments: $10,530